![](/img/cover-not-exists.png)
A573 Phase I Trial of CCI-779 and Weekly Bortezomib in Relapsed and/or Refractory Multiple Myeloma
Roccaro, AM, Leduc, R, Nelson, M, Sam, A, Chuma, S, Colson, K, O'Connor, K, Ghobrial, IM, Munshi, NC, Schlossman, R, Harris, B, Warren, D, Dollard, AM, Laubach, J, Vij, R, Campagnaro, E, Birner, A, DiVolume:
9
Language:
english
Journal:
Clinical Lymphoma and Myeloma
DOI:
10.1016/s1557-9190(11)70622-9
Date:
February, 2009
File:
PDF, 92 KB
english, 2009